Shionogi to Acquire Intrabio Inc. for Rare Disease Expansion
Shionogi & Co., Ltd. announced its planned acquisition of Intrabio Inc. as part of its ongoing expansion in the rare disease sector.
Story updates
06:06:18 AM UTC
SquawkNews
Shionogi: To Buy IntraBio for $2 Billion >4507.TO
06:29:40 AM UTC
SquawkNews
Shionogi: To Acquire Shares of IntraBio From Individuals, Trusts, Corporate Entities, Other Shareholders